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Extracellular matrix (ECM) degrading enzymes produced by Clostridium perfringens may
play an important role during the initial phases of avian necrotic enteritis by facilitating toxin
entry in the intestinal mucosa and destruction of the tissue. C. perfringens is known to
produce several ECM-degrading proteases, such as kappa toxin, an extracellular
collagenase that is encoded by the colA gene. In this study, the colA gene sequence of
a collection of 48 C. perfringens strains, including pathogenic (i.e. toxinotype G) and
commensal (i.e. toxinotype A) chicken derived strains and strains originating from other
host species, was analyzed. Although the colA gene showed a high level of conservation
(>96% nucleotide sequence identity), several gene variants carrying different nonsense
mutations in the colA gene were identified, leading to the definition of four truncated
collagenase variant types (I-IV). Collagenase variant types I, III and IV have a (nearly)
complete collagenase unit but lack parts of the C-terminal recruitment domains, whereas
collagenase variant types II misses the N-terminal part of collagenase unit. Gene
fragments encoding a truncated collagenase were mainly linked with necrotic enteritis
associated C. perfringens type G strains with collagenase variant types I and II being the
most prevalent types. Gelatin zymography revealed that both recombinant full-length and
variant type I collagenase have active auto-cleavage products. Moreover, both
recombinant fragments were capable of degrading type I as well as type IV collagen,
although variant type I collagenase showed a higher relative activity against collagen type
IV as compared to full-length collagenase. Consequently, these smaller truncated
collagenases might be able to break down collagen type IV in the epithelial basement
membrane of the intestinal villi and so contribute to the initiation of the pathological
process leading to necrotic enteritis.
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Collagens are major glycoproteins of the extracellular matrix and
play an important role in maintaining the biological and
structural integrity of various tissues and organs in both
humans and animals (Rozario and DeSimone, 2010). Being
ubiquitously present, collagens are attractive targets for various
microorganisms to induce tissue destruction (Bober et al., 2010;
Singh et al., 2012). Indeed, many different bacterial pathogens,
including members of the Clostridium genus, have been shown to
produce collagenolytic enzymes (Harrington, 1996; Duarte et al.,
2016). By digesting the collagen-rich extracellular matrix (ECM),
pathogens can facilitate their own colonization and spread
through the host tissues (Matsushita and Okabe, 2001; Duarte
et al., 2016). Additionally, digestion of ECM compounds
contributes to the availability of amino acids for the pathogen’s
survival and growth and can also favor toxin diffusion and tissue
damage (Kalisz, 1988; Harrington, 1996; Singh et al., 2012;
Tomlin and Piccinini, 2018).
Clostridium (C.) perfringens is one of the collagenase-
producing Clostridia and is known to cause a variety of
histotoxic and enterotoxic diseases in both humans and
animals (Niilo, 1980; Uzal et al., 2010). Although toxicity of
C. perfringens is mostly dependent on the production of specific
toxins, extracellular proteolytic enzymes are thought to assist in
the development of some diseases. C. perfringens has been shown
to produce multiple gelatinolytic enzymes with molecular masses
ranging from ~80 to approximately ~120 kDa (Kameyama and
Akama, 1971). The 80 kDa collagenase, which was formerly
designated as kappa toxin, is lethal for mice upon intravenous
injection and has both hemorrhagic and dermonecrotic activities
upon subcutaneous injection in guinea pigs (Kameyama and
Akama, 1971). Since the mid-90s, the focus of scientific research
has shifted from the 80 to the 120 kDa collagenase and the term
kappa toxin was revised, now denoting the ~120 kDa enzyme
(Obana et al., 2010; Obana et al., 2013). This enzyme is encoded
by the chromosomal colA gene and is synthesized as a precursor
enzyme (pre-pro-collagenase; 126 kDa) with an N-terminal
stretch of 86 amino acids containing a putative signal sequence
and a pro-region. Within this pro-region, a collagenase target
sequence is present, suggesting that self-processing is involved in
maturation of the collagenase enzyme (Kameyama and Akama,
1971). Removal of the signal peptide and pro-sequence generates
a mature extracellular collagenase (116 kDa) composed of a
collagen binding module, a polycystic kidney disease-like (PKD-
like) domain and a collagenase module, which contains a zinc-
binding sequence (HEXXH) at the center of the active site
(Matsushita et al., 1994). The C. perfringens collagenases have
been studied mostly with respect to their role in the pathogenesis
of gangrene. Little research, however, has been conducted on the
role of the clostridial collagenases in intestinal disease.
Necrotic Enteritis (NE) is an enteric disease of broiler
chickens which is caused by avian-specific, NetB toxin
producing strains of C. perfringens (i.e. toxinotype G strains)Abbreviations: NE, necrotic enteritis; C. perfringens, Clostridium perfringens;
ECM, extracellular matrix.
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NetB toxin is a key virulence factor in the development of
necrotic ulcers which are typical for NE. Yet, where and how
NetB initiates this process is not fully understood (Keyburn et al.,
2008; Rood et al., 2016). A recent study focusing on the gene
expression during colonization of the chicken intestinal tract by
C. perfringens showed that NetB expression is not upregulated
during the early stages of disease. It is currently believed that the
toxin targets deeper layers of the intestinal mucosa rather than
superficial structures (Parreira et al., 2016). As a consequence,
initial breakdown or permeabilization of the intestinal mucosa
might be needed in order for NetB to exert its action. This
permeabilization might be caused by a combination of factors
such as agents causing epithelial damage [e.g. Eimeria spp. (Al-
Sheikhly and Al-Saieg, 1980) or mycotoxins (Ren et al., 2019)],
either or not in combination with collagenolytic enzymes which
could affect the connective tissue and basement membrane in the
intestinal mucosal layer, and thus initiate lesions (Olkowski et al.,
2006; Olkowski et al., 2008). C. perfringens strains isolated from
field cases of NE secrete several potent collagenolytic enzymes
and the expression of the colA gene is upregulated during the
early stages of NE (Olkowski et al., 2008; Parreira et al., 2016),
suggesting a potential role in the initial stages of the pathogenesis
of NE.
The aim of the present study was to elucidate whether kappa
toxin (~120 kDa collagenase encoded by colA) from avian
pathogenic (NetB positive) C. perfringens strains (i.e. toxinotype G)
differs from that of commensal (NetB negative) chicken-associated
C. perfringens strains (i.e. toxinotype A) both in its sequence
and function.MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The colA gene sequences of 25 C. perfringens strains originating
from chickens and 23 strains from non-chicken origin were used
in this study (Table 1). This collection contains strains which
were derived from a range of international locations and host
disease statuses. From these strains, a selection of 21 chicken-
associated C. perfringens strains were cultured, either for DNA
extraction or for functionality assays (Table 1). C. perfringens
strains were routinely grown on Columbia agar (Oxoid) plates
supplemented with 5% defibrinated sheep blood or in Brain
Heart Infusion broth (BHI, Oxoid, Basingstoke, UK) under
anaerobic conditions at 37°C.
Escherichia (E.) coli TOP10 cells were used as the cloning host
for recombinant expression of collagenase and were routinely
grown on LB medium (Fisher Scientific, Merelbeke, Belgium)
supplemented with 100 mg/ml of ampicillin. Terrific Broth (24%
Tryptone, 42% Yeast extract, 4% glycerol, 0.72 M Na2HPO4, 0.16
M NaH2PO4) was used for recombinant protein production.
Growth Curves
Growth curves were performed for a subset of 9 chicken-
associated C. perfringens strains (Table 1). Overnight grown
cultures were diluted 1/10,000 in fresh BHI broth and incubatedApril 2021 | Volume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colATABLE 1 | Characteristics of C. perfringens strains used in this study.

















Roach et al., 2015










Medvecky et al., 2018
ATCC_13124 Type A Human n/a Gas gangrene CP000246 Full-
length
Möllby et al., 1976
CP15 Type A Chicken Delaware, USA Healthy CP019468.1 Full-
length
Li et al., 2020
CP23 Type G Chicken Belgium Healthy MW3935361 Type II X Gholamiandekhordi
et al., 2006








CP56 Type G Chicken Belgium Necrotic enteritis MW3935281 Type IA X Gholamiandekhordi
et al., 2006
CP60 Type G Chicken Belgium Necrotic enteritis MW3935321 Type IB Gholamiandekhordi
et al., 2006
CP61 Type G Chicken Belgium Necrotic enteritis MW3935331 Type IB Gholamiandekhordi
et al., 2006
D13 Type G Chicken Denmark Necrotic enteritis MW3935381 Type III this study
D15 Type G Chicken Denmark Necrotic enteritis MW3935351 Type IB this study
D2 Type G Chicken Denmark Necrotic enteritis MW3935341 Type IB X this study
D3 Type G Chicken Denmark Necrotic enteritis MW3935271 Full-
length
this study
D4 Type A Chicken Denmark Necrotic enteritis MW3935461 Type II this study
D8 Type G Chicken Denmark Necrotic enteritis MW3935341 Type II X this study
Del1 Type G Chicken Delaware, USA Necrotic enteritis CP019576.1 Type II Li C. et al., 2017
EHE-NE15 Type G Chicken Australia Necrotic enteritis MW3935301 Type IA Sheedy et al., 2004
EHE-NE18 Type G Chicken Australia Necrotic enteritis CP025501.1 Type IA X Sheedy et al., 2004
EHE-NE5 Type G Chicken Australia Necrotic enteritis MW3935291 Type IA Sheedy et al., 2004
F4969 Type A Human n/a Diarrhoea NZ_ABDX00000000.1 Full-
length
Cornillot et al., 1995
FORC003 Type A Aquarium
water
South Korea n/a CP009557.1 Full-
length
Kiu et al., 2017


















JGS1495 Type C Pig n/a Diarrhoea GCA_000171135.1 Full-
length
Fisher et al., 2006
JGS1721 Type D Sheep n/a Enterotoxaemia NZ_ABOO00000000.1 Full-
length
Hassan et al., 2015




Lepp et al., 2010
JGS4104 Type A Chicken USA Necrotic enteritis MW3935451 Type II Cooper and Songer,
2010
JIR4857 Type A Chicken Australia Necrotic enteritis MW3935411 Full-
length
X Van Damme et al., 2020
JJC Type A Landfill Malaysia n/a AWRZ01000000 Full-
length
Wong et al., 2014
JP55 Type A Foal Canada Necrotizing
enteritis
CP010993 Type IV Mehdizadeh Gohari
et al., 2016


















MJR7757A Type A Human n/a Unknown NZ_LRPU00000000.1 Full-
length
Ribeiro et al., 2012
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measuring the optical density at 600 nm (Genesys 10S UV‐vis
spectrophotometer, Thermo Scientific, Waltham, MA, USA) at 0,
1, 2, 3, 4, 5, 6 and 24 h after inoculation. At each timepoint, 1 mL
aliquots from each culture were collected to obtain cell-free
supernatants by centrifugation of the samples, followed by
filtration of the supernatants through a 0.2 μm filter and stored
at -20°C, until further use in zymography (see below).
Zymography
Supernatant aliquots of 10 μL were mixed with 2 × loading buffer
(0.5 M Tris–HCl pH 6.8, 20% glycerol, 4% SDS, a pinch of
bromophenol blue) and separated on 8% SDS page containing
0.1% gelatin under non-reducing conditions. After separation,
the gel was incubated with renaturing buffer (2.5% Triton X-100,
30 min, room temperature) to remove SDS from the gel. This
allows the separated enzymes in the gel to renature and restores
enzymatic activity. Subsequently, the gel was washed with
developing buffer (150 mM NaCl, 5 mM CaCl2, 0.05% NaN3
and 50 mM Tris–HCl buffer pH 7.5) and incubated with fresh
developing buffer under continuous shaking at 37°C for 18 h.
Afterwards, the gel was stained for 1h with Coomassie brilliant
blue G-250 (Sigma-Aldrich, Bornem, Belgium) and destained for
20 minutes with destaining solution [40% methanol (v/v), 10%
acetic acid (v/v)]. Activity of gelatin-degrading enzymes is visible
as clear colourless bands against a blue background. Gels were
scanned using a GS-800 calibrated densitometer and the
intensities of the gelatinolytic bands were determined using the
Quantity One software (BioRad, Hercules, CA, USA). Values
were normalized against the background and expressed as
arbitrary unitsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4(A :U) = 100 ∗ (1 −
OD
mm2
  of   sample
OD
mm2
  of   background
)
Assessment of colA Sequence Variants
Retrieval of colA Sequences From
Published Sequences
EHE-NE18 colA sequence was obtained from NCBI and a
BLASTn search was performed for C. perfringens (tax ID:
1502) genomes across all annotated strains. ColA gene
sequences of 28 C. perfringens strains (including 5 chicken-
associated and 23 non-chicken-associated C. perfringens
strains) were acquired from the NCBI genome database
(Table 1).PCR Amplification and Sanger Sequencing
of the colA Genes
The colA gene of a set of 20 chicken-associated C. perfringens
strains from which no whole genome sequencing data was
publicly available, was amplified by PCR and sequenced by
Sanger sequencing (Table 1). Genomic DNA was extracted
using alkaline lysis as previously described (Scheirlinck et al.,
2007). Amplification of the colA genes was performed in a total
reaction volume of 50 ml containing 0.5 μL dNTPMix (100 mM),
2 mL DNA template, 1 μL Velocity DNA Polymerase, 1× Hi-Fi
Buffer (Bioline, London, UK) and 0.4 mM of primers (Figure 1).
Thermal cycling conditions: initial denaturing step of 98°C for
2 min, followed by 35 amplification cycles of 98°C for 30 s, 50°C
for 1 min, and 72°C for 3 minutes and a final extension step of
72°C for 10 min. Presence of a single PCR band was verified by
electrophoresis on 1.5% agarose gels. Sanger sequencing wasTABLE 1 | Continued











N11 Type A Chicken Maryland, USA Healthy CP023410 Full-
length
Li C. et al., 2017
NAG-NE24 Type A Chicken Australia Necrotic enteritis MW3935441 Full-
length
Sheedy et al., 2004




NCTC 2837 Type A Unknown n/a Unknown NZ_ABDY00000000.1 Full-
length
Hauduroy et al., 1937
NCTC 8239 Type A Human The
Netherlands
Food poisoning NZ_CABPRS010000001.1 Full-
length
Hobbs et al., 1953
PK406 Type A Chicken Belgium Necrotic enteritis MW3935431 Full-
length
this study
PM69 Type G Chicken Belgium Necrotic enteritis MW3935311 Type IA this study
S2 Type A Chicken Denmark Necrotic enteritis MW3935421 Full-
length
X this study
SM101 Type A Human n/a Food poisoning CP000312.1 Full-
length
Li J. et al., 2017
Strain13 Type A Human n/a Gas gangrene BA000016.3 Full-
length
Shimizu et al., 2001
WAL_14572 Type A Human n/a Unknown NZ_ADLP00000000.1 Full-
length
Ribeiro et al., 2012April 2021 | Vo1Sequence derived by sanger sequencing performed in this study as described in materials & methods.
2classification of colA types based on the presence of non-sense mutation in the colA gene.
3proteolytic activity confirmed by zymography at different stages of bacterial growth.lume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colAperformed by Eurofins Genomics (Ebersberg, Germany). As a
single Sanger sequencing run generates a read of up to 1000
basepairs and the colA nucleotide sequence is ±3315 bp long,
multiple internal sequencing primers were designed to make sure
the entire gene sequence was covered. Design of all primers was
based on a multiple sequence alignment of the publicly available
colA sequences. All primers used in this work are shown in
Figure 1. Nucleotide sequences are available in the GenBank
sequence database under accession numbers MW393527
to MW393546.
Genetic Analysis of the colA Genes
The amino acid sequences encoded by the colA gene of
48 C. perfringens strains (Table 1) were deduced bioinformatically
using the ExPASy Translate tool (https://web.expasy.org/translate).
The domain architecture of the deduced protein fragments was
retrieved by performing an NCBI Conserved Domain search and
the molecular weights of the mature collagenase fragments (i.e.
excluding the pre-pro domains) were calculated using the ExPASY
pI/MW tool (https://web.expasy.org/compute_pi). Nucleotide and
deduced amino acid sequence data were aligned by the ClustalW
alignment algorithm using Mega version X and the alignment was
visualized by BOXSHADE (Kumar et al., 2018). Dendrograms of
full-length sequences of the colA genes (including both fragments
when nonsense mutations leading to premature stop codons are
present) were constructed by multiple alignment-based similarity
coefficients and UPGMA (unweighted pair group method with
arithmetic mean) cluster analysis using BioNumerics version 7.6.3
(Applied Maths, Sint-Martens-Latem, Belgium).
Recombinant Production
Full-length and truncated colA gene products were expressed in
E. coli TOP10 cells using the pBAD TOPO® TA Expression Kit
(Invitrogen, Paisley, UK). The desired fragments were amplified
from the DNA of C. perfringens strains CP56 and CP24Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5(for respectively the full-length and truncated colA gene) by
PCR using a DNA polymerase with proofreading activity
(Velocity DNA Polymerase, Bioline, Brussels, Belgium). The
forward primer (FWD_rColA, Figure 1) contained an in-
frame stop codon and translation re-initiation sequence to
remove the N-terminal leader sequence and allow native
protein expression. The reverse primers (REV_rColA_full or
REV_rColA_trunc, Figure 1) excluded the native colA gene stop
codon and included the C-terminal V5 epitope and poly-histidine
region for affinity purification. Amplifications were performed in a
total reaction volume of 50 ml containing 0.5 μL dNTP Mix (100
mM), 2 mL DNA template, 1 μL Velocity DNA Polymerase, 1× Hi-
Fi Buffer (Bioline) and 0.4 mMof primers. PCR conditions used for
the amplification were an initial denaturation at 95°C for 4 min
followed by 35 cycles of denaturation at 95°C for 1.5 min,
annealing at 53.8°C for 30 s and extension at 72°C for 2 min,
and a final extension step at 72°C for 10 min. The resulting PCR
product was incubated with Taq polymerase for 10 min at 72°C
(5 U; Promega, Madison, WI, USA) to add 3’ A-overhangs, cloned
into the pBAD-TOPO expression vector (Invitrogen, Merelbeke,
Belgium), and transformed into One Shot TOP10® E. coli
(Invitrogen) according to the manufacturer’s instructions. The
correct orientation of inserts was verified by Sanger sequencing.
Recombinant E. coli carrying the pBAD-collagenase vectors
were grown in Terrific Broth supplemented with 100 μg/mL
ampicillin at 37°C until an OD600 of 0.5 was reached. Expression
of the recombinant full-length and truncated rColA was induced
overnight with 0.2% L-arabinose (w/v). Bacteria were harvested
by centrifugation and lysed enzymatically using BugBuster
(Invitrogen, Merelbeke, Belgium). Recombinant proteins were
purified on a Ni-sepharose column (His Gravitrap, GE
Healthcare Bio-Sciences AB, Uppsala, Sweden) according to
the manufacturer’s instructions. Subsequently, proteins were
dialyzed against PBS, purity was analysed using SDS-PAGE,
and protein concentration was measured using BCA proteinFIGURE 1 | Primers used in this study and their relative position in colA. Positions are based on C. perfringens strain EHE-NE18 colA sequence.April 2021 | Volume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colAassay (Fisher Scientific). Activity of the recombinant proteins
was analysed by gelatin zymography (0.5 μg protein load) as
described above.
Gelatinase/Collagenase Activity Assay
The Molecular Probes EnzChek® Gelatinase/Collagenase Assay
Kit was used to evaluate the activity of the recombinant
collagenase fragments using DQ™ Gelatin (proxy for total
collagenolytic activity), DQ™ Collagen I (activity against
fibrillar collagen) and DQ™ Collagen IV (activity against non-
fibrillar collagen). Different recombinant enzyme concentrations
(5 μg/mL, 1 μg/mL or 0.1 μg/mL) were used to avoid effects of
enzyme-substrate interactions. In a 96-well format, 50 μL of each
recombinant sample was mixed with 130 mL of reaction buffer
(0.5 M Tris–HCl, 1.5 M NaCl, 50 mM CaCl2 and 2 mM sodium
azide at pH 7.6) and 20 μL of either fluorescein labelled substrate
(DQ Collagen I (25 mg/mL), DQ Collagen IV (25 mg/mL) or DQ
Gelatin (12.5 mg/mL)). Samples without enzyme activity served
as control for auto-fluorescence. Reactions were incubated for
60 min at room temperature in the absence of light, and
fluorescence was measured every 5 min (excitation 485 nm,
emission 527 nm; Fluoroskan Ascent Fluorometer, Thermo
Fisher Scientific). Activity of the recombinant collagenase
fragments against each substrate was calculated through the
slope of the linear phase (first 30 minutes) of the fluorescence
resulting from the cleavage of the respective fluorescein labelled
substrate over time
enzyme   activity =
slope   enzyme − slope   blankð Þ     dilution   factor
0, 001     enzyme   volume
 
Subsequently, the activity of each recombinant fragment against
collagen type I or IV was normalized against its total
collagenolytic activity and the ratio
relative   enzyme   activity  collagenase   variant   I
relative   enzyme   activityfull−length   collagenase
was calculated. One-sample t-tests were performed to evaluate
whether the ratios differed significantly from 1, i.e. the ratio value
that corresponds with an equal activity of both collagenase
variant I and full-length collagenase. All statistical analyses
were performed using GraphPad Prism software (version 5.03,
San Diego, CA, USA).RESULTS




To determine whether pathogenic C. perfringens type G strains
harbor different collagenolytic properties as compared to
commensal C. perfringens type A strains, the in vitro
collagenase production of two type G strains with proven
pathogenic activity (CP56 and EHE-NE18) was compared toFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6two commensal C. perfringens type A isolates (JIR4857; proven
to be non-pathogenic and CP24; isolated from a healthy chicken)
(Gholamiandekhordi et al., 2006; Gharib-Naseri et al., 2019; Van
Damme et al., 2020). Both C. perfringens type A strains showed 1
major band of activity at ± 116 kDa and 3 minor bands with
molecular masses between 75 and 110 kDa. Remarkably, a
different pattern was seen for the C. perfringens type G strains.
For both of these strains a major band of molecular size 80-90
kDa and a fainter band of ±75 kDa was observed (Figure 2). The
116 kDa collagenase band, which is the predicted height of the
colA gene product was absent in both tested pathogenic type
G strains.
Truncated Collagenase Variants Are
More Frequently Found in Chicken
C. perfringens Type G Strains
To explain the appearance of these different gelatinolytic profiles,
the sequences of the colA gene of a collection of 48 C. perfringens
strains were compared. Overall, the colA sequences were highly
similar at nucleic acid level (> 96.6% sequence identity).
Variations due to deletions, insertions and single-nucleotide
polymorphisms were observed in 259 out of the 3316
nucleotide positions. Comparative analysis of the deduced
amino acid sequences demonstrated that there were multiple
variants containing nonsense mutations leading to the
expression of truncated collagenase fragments (Supplementary
Figure S1). Genetic variants were classified in different
collagenase variant types (I to IV) based on the location of the
nonsense mutation and the predicted protein domain structure
of the corresponding protein fragments (Figure 3 and Table 1).FIGURE 2 | Gelatinolytic activities expressed by different C. perfringens
strains. Supernatant samples of 2 C. perfringens type A strains (JIR4857,
CP24) and 2 C. perfringens type G strains (EHE-NE18, CP56) were analyzed
for proteolytic activity by gelatin zymography. Lane L, Protein Ladder
(Precision Plus Protein All Blue Pre-stained Protein Standards, Biorad).April 2021 | Volume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colAThe full-length collagenase is synthesized as a multimodular
pre-pro-protein (predicted MW~ 126 kDa) which is subsequently
processed to its mature extracellular form (~ 116 kDa). This
mature form consists of a collagenase module (containing an
M9N activator domain, an M9 peptidase domain with an HEXXH
zinc-binding motif and a helper domain), a polycystic kidney
disease-like (PKD-like) domain and 2 collagen-binding domains
(CBD1 and CBD2) (Kameyama and Akama, 1971). Full-length
collagenase sequences were present in 95.65% of the non-chicken
derived C. perfringens strains and 81.82% of the chicken-derived
C. perfringens type A strains. By contrast, only 7.14% of the
chicken-derived C. perfringens type G strains encode the full-
length protein (Figure 3).
All truncated collagenase variant types are encoded by gene
variants carrying a premature stop mutation in the colA gene
which results in the occurrence of 2 coding sequences. For each
of these variant types, the first coding sequence corresponds to
the truncated protein at the N-terminal part of the full-length
protein, which encodes a signal-sequence, while the second
coding sequence corresponds to the truncated protein at the C-
terminal part of the full-length protein, which lacks any secretion
signal (Figure 3). As a consequence, only the fragment encoded
by the first coding sequence will be secreted. For collagenase
variant type I, this results in an active secreted fragment that
contains a complete collagenase module and PKD domain yet
lacks the 2 collagen binding domains. Depending on the location
of the premature stop codon, two subtypes (e.g. type IA and IB)
can be described which both encode a similar active collagenase
protein (type I variant). The main difference between these
subtypes is found in the second gene fragment, which encodes
either both CBD domains (variant type IA) or only a single CBD
domain (variant type IB). Both type I variants are exclusivelyFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7present in C. perfringens type G strains (respectively present in
35.7% and 28.6% of the type G strains) (Figure 3).
Collagenase type II variants were present in 18.2% of the
chicken-derived C. perfringens type A strains and 21.4% of the
type G strains and were absent in non-chicken derived C.
perfringens strains. Unlike all other collagenase variant types, the
2 coding sequences of collagenase type II variants are located on
overlapping open reading frames. As a result, the M9 peptidase-
domain is encoded in part by the first and in part by the second
coding sequence. Only the second fragment is predicted to be active
as it contains the conserved HEXXH motif which is characteristic
for the catalytic center of a metalloproteinase. Besides a partial,
HEXXH-containing M9 peptidase domain, this fragment also
contains the collagenase helper domain, the PKD-like domain
and 2 CBDs, yet it lacks secretion signal sequence, indicating that
the protein cannot be secreted by the bacteria (Figure 3).
The third collagenase variant type (= type III) is uniquely
present in one C. perfringens type G strain. In this type, the
longest sequence encodes a fragment containing the pre-pro-
region, the collagenase module and a small part of the PKD-like
domain, while the other coding sequence only encodes the
domains which are responsible for collagen binding.
In contrast to the collagenase variant types I, II and III, which
were exclusively found in chicken-derived C. perfringens strains,
the fourth collagenase variant type (type IV) was unique for one
non-chicken derived C. perfringens strain. The colA gene of the
collagenase type IV variant encodes a first fragment containing
the pre-pro-region and a part of the collagenase module (i.e. half
of the peptidase helper domain is missing) and a second
fragment consisting of the other half of the helper domain, the
PKD-like domain and both CBDs. The former fragment is
expected to be active upon maturation (Figure 3).FIGURE 3 | Schematic representation and distribution of collagenase variants. Schematic representation of the domain architecture of full-length and truncated
collagenase types and their distribution among chicken (type G and type A strains) and non-chicken derived C. perfringens strains (respectively n=14, n=11 and
n=23). PRE = signal sequence, PRO = pro-domain, M9N = activator domain, M9 = peptidase domain, HELPER = peptidase helper domain, PKD = polycystic kidney
disease-like domain and CBD = collagen binding domains. Collagenase variant types are encoded by gene variants carrying a premature stop mutation in the colA
gene which results in the occurrence of 2 protein-coding regions. Predicted active fragment containing the HEXXH motif is represented in dark grey, while the other
fragment which is expected to be inactive is represented in light grey. *PRE & PRO domains are removed upon maturation. Molecular weight of the predicted mature
active fragment is given.April 2021 | Volume 11 | Article 645248
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Collagenase Variants
A UPGMA phylogenetic tree was constructed based on the colA
gene sequences (i.e. full gene sequence including both fragments
when nonsense mutations leading to premature stop codons are
present) of a collection of 48 C. perfringens strains (Figure 4). In
general, C. perfringens strains encoding the same collagenase
variant type clustered together showing very similar (e.g. type IB)
or even identical (e.g. type IA or type II) nucleotide sequences. In
contrast, C. perfringens strains encoding the full-length collagenase
were found more scattered throughout the phylogeny and branch
at various depths in the phylogeny, reflecting a higher diversity
between these strains.
Activity Confirmation of the Different
Collagenase Variant Types
All collagenase variant types were predicted to be catalytically active as
they all contain an intact HEFTH (HEXXH) motif (Supplementary
Figure S1). In order to verify this, a zymographic analysis was
performed on supernatant samples of 9 C. perfringens strains
encoding for the most common collagenase types (i.e. full-length
collagenase (n=4), variant type I (n=2 for subtype IA and n=1 for
subtype IB) and variant type II strains (n=2) (Table 1 and Figure 5).
All strains encoding the full-length collagenase showed
proteolytic activity at the predicted molecular weight of 116
kDa in the early log phase. Later in growth, several catalytically
active fragments with molecular weights ranging from 116 to
approximately 80 kDa were observed. Likewise, strains encoding
the collagenase type I variants, showed a single band of activity at
the expected height (~ 90 kDa or ~ 95 kDa) early in growth,
while on later time points one or more additional lower
molecular weight band(s) (<75 kDa) became visible. In one
strain, an additional band of higher molecular weight (90-110
kDa) was observed (strain S2, data not shown).
Type II variant collagenases lack a signaling peptide needed
for protein secretion (described above), resulting in either no
gelatinolytic activity observed in the supernatants (strain CP23,
data not shown) or one very faint band of ± 140 kDa, which
corresponds to the molecular weight of the dimeric form of the
mature variant II collagenase fragment (monomer ~ 71 kDa) and
might be released in the supernatants as the result of release of
intracellular proteins from disrupted dead bacteria.
Both Recombinant Full-Length and Variant
Type I Collagenase Have Active Auto-
Cleavage Products
Gelatin zymography confirmed that both the full-length and type I
recombinant collagenase fragments have gelatinolytic activity
(Figure 6). Both proteins showed activity at the predicted height
together with an active fragment at a lower molecular weight. For
the full-length recombinant collagenase, both observed bands (~120
kDa and ~90-100 kDa) accounted for approximately half of the
gelatinolytic activity (respectively ± 49% and ± 51%). For the type I
recombinant collagenase, the predicted fragment (~94 kDa), only
accounted for 26% of the activity, while the breakdown product
(~75 kDa) accounted for 74% of the gelatinolytic activity, evenFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8though both fragments accounted for similar portions (respectively
27 and 33%) of the total protein detected on SDS-page.
The relative enzyme activity of recombinant full-length and
truncated variant type I collagenase against interstitial (type I)
and non-fibrillar (type IV) collagen was determined. Both
recombinant fragments were capable of degrading type I and
type IV collagen. Moreover, the variant type I collagenase
showed a higher relative activity against collagen type IV as
compared to full-length collagenase (t=11.69, df=2, p=0,0072),
whereas no statistically significant difference in activity was seen
against collagen type I (t=0.2750, df=2, p=0,8091) (Figure 6C).DISCUSSION
Bacterial collagenases are enzymes involved in the degradation of
the extracellular matrix due to their ability to digest native
collagen. These enzymes might play a role in C. perfringens-
induced NE by facilitating toxin entry in the intestinal mucosa
and by destruction of the tissue structure (Kalisz, 1988;
Harrington, 1996; Singh et al., 2012; Tomlin and Piccinini,
2018). In the past, C. perfringens has been shown to produce
various gelatinolytic enzymes with molecular masses ranging
from approximately 120 to approximately 80 kDa. Yet, only one
gene (colA) encoding the 120-kDa collagenase was identified and
characterized (Kameyama and Akama, 1971).
In this study, several gene variants carrying different nonsense
mutations in the colA gene were identified which were mainly
linked to C. perfringens type G strains, that are pathogenic for
broiler chickens. Indeed, although the colA gene showed a high level
of conservation (> 96% nucleotide sequence identity), truncating
variants were identified encoding four different collagenase variant
types (type I to IV). These truncated collagenase variants were
detected in 13 out of the 14 investigated C. perfringens type G
strains, which originated from four different countries, on three
different continents (USA, Europe and Australia). This indicates
that the observed association of truncated collagenase versions with
Type G strains is widespread and not due to single mutation event.
The most prevalent collagenase variant types were type I (9/48) and
II (5/48), whereas both collagenase type III and IV were present in
only 1 of the analyzed C. perfringens strains. All collagenase variant
types were predicted to be active as they all contain an intact
HEXXH motif which is characteristic for the catalytic center of a
metalloproteinase. However, little to no gelatinolytic activity was
observed in the supernatant of strains encoding type II variant
collagenases. This might be due to the fact that this collagenase type
lacks a signaling peptide needed for protein secretion, or because it
is inefficiently transcribed. The active fragments of collagenase
variant types I, III and IV have a (nearly) complete collagenase
module but lack parts of the recruitment domains (i.e. type I and III
miss the CBD domains, type IV misses both PKD and CBD
domains). Studies using the ColG collagenase from Clostridium
histolyticum showed that these recruitment domains are needed to
degrade dense collagen networks, such as fibrils, but are not
required for the degradation of triple helical collagen (Eckhard
and Brandstetter, 2011; Eckhard et al., 2011). However, in this studyApril 2021 | Volume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colAFIGURE 4 | colA gene based dendrogram reflecting the similarity for 48 C. perfringens strains. A UPGMA phylogenetic tree was constructed based on the colA
gene sequences (i.e. full gene sequences - from original start to original stop codon - including both fragments when nonsense mutations leading to premature stop
codons are present). Sequence similarity percentages (top bar) are shown. Colored branches depict collagenase variant types (see Figure 3, Green, full-length;
Red, collagenase type I variant; Blue, collagenase type II variant; Light blue, collagenase type III variant; Orange, collagenase type IV variant). Branch labels include
the C. perfringens strains from which the colA gene sequence was derived.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org April 2021 | Volume 11 | Article 6452489
Van Damme et al. Protein Truncating Variants in colAFIGURE 5 | Analysis of proteolytic activity at different stages of growth of C. perfringens strains encoding for 3 different collagenase types. Growth was analyzed by
measuring optical density at 600 nm at 8 timepoints (0, 2, 3, 4, 5, 6, 7 and 24 h post inoculation). At each timepoint supernatant samples were collected and
analyzed by zymography. The observed bands were measured by Quantity One to determine the relative gelatinolytic activity. AU = arbitrary units. One representative
image per collagenase variant type is shown (full-length collagenase: JIR4857, type I: CP56 and type II: D8).A B C
FIGURE 6 | Recombinant full-length and variant type I collagenase have active auto-cleavage products. (A) SDS page and (B) Gelatin zymography of the
recombinantly expressed collagenase fragments. F = full-length collagenase, expected fragment 120 kDa; T = Type I variant collagenase, expected fragment 94 kDa;
M1= Pageruler plus pre-stained, M2 = Precision Plus protein All blue Pre-stained Protein standard. (C) Substrate-degrading activity of both the full-length
collagenase and variant type I collagenase towards collagen type I or collagen type IV was measured using the EnzChek collagenase assay. The bar shows the
activity of the variant type I collagenase relative to the full-length collagenase towards each of the tested substrates. Data represents mean ± standard deviations
(n=3). One-sample t-tests were performed to evaluate whether the ratios differed significantly from 1, i.e. the ratio value that corresponds with an equal activity of
both collagenase variant I and full-length collagenase. **p ≤ 0,01.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org April 2021 | Volume 11 | Article 64524810
Van Damme et al. Protein Truncating Variants in colAwe showed that recombinant variant type I collagenase - which
misses the CBD domains - was able to degrade both interstitial
(collagen type I) and non-fibrillar (collagen type IV) collagens. It
also had a higher relative activity against collagen type IV as
compared to recombinant full-length collagenase. Type IV
collagen is the major structural scaffold of basement membranes
(Sand et al., 2019). Consequently, these truncated collagenases
might be able to break down collagen type IV in the epithelial
basement membrane of the intestinal villi. As such, they can
contribute to the pathogenesis of NE, as the process leading to
intestinal mucosal necrosis has been shown to start at the level of
the basement membrane and the lateral domain of the enterocytes
(Olkowski et al., 2006; Olkowski et al., 2008). Moreover, the loss of
the collagen binding domains in these collagenase variants might
allow them to more freely and transiently interact with collagens in
the extracellular matrix, potentially leading to a higher non-specific
activity resulting in an undefined breakdown of the ECM
surrounding the cells, and so contributing to the pathogenesis.
Even more, epithelial damage because of predisposing factors such
as Eimeria might cause easy accessibility to structures underlying
the epithelial cells, so that these collagenases can cause further
damage to the initial lesion.
Based on the results of our genetic analysis, we showed that
genes encoding for a truncated collagenase are more frequently
found in pathogenic C. perfringens type G strains as compared to
commensal chicken-derived C. perfringens type A strains or
strains originating from other host species, which indicates that
having a smaller collagenase might provide an advantage for the
bacteria. Indeed, using recombinant collagenase fragments, we
showed that both the full-length and variant type I collagenase
undergo (auto)proteolysis which results in smaller, but still active
collagenase fragments. Additionally, we showed that the cleavage
product of the type I collagenase accounts for more of its
gelatinolytic activity than the original fragment, despite both
fragments being present in approximately equal amounts. It is
plausible that these smaller collagenases (e.g. truncated variants)
might more efficiently migrate in the mucus layer and/or host
tissue. This is an issue for future work to explore.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11DATA AVAILABILITY STATEMENT
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Dictionnaire Des Bactéries Pathogènes Pour L’homme, Les Animaux Et Les
Plantes (Paris: Masson et cie).
Hobbs, B. C., Smith, M. E., Oakley, C. L., Warrack, G. H., and Cruickshank, J. C.
(1953). Clostridium Welchii Food Poisoning. J. Hyg. 51, 75–101. doi: 10.1017/
S0022172400015515
Kalisz, H. M. (1988). Microbial Proteinases. Adv. Biochem. Eng. Biotechnol. 36, 1–
65. doi: 10.1007/BFb0047944
Kameyama, S., and Akama, K. (1971). Purification and Some Properties of Kappa
Toxin of Clostridium Perfringens. Jpn. J. Med. Sci. Biol. 24, 9–23. doi: 10.7883/
yoken1952.24.9
Keyburn, A. L., Boyce, J. D., Vaz, P., Bannam, T. L., Ford, M. E., Parker, D., et al. (2008).
Netb, a New Toxin That is Associated With Avian Necrotic Enteritis Caused by
Clostridium Perfringens. PloS Pathog. 4 (2), e26. doi: 10.1371/journal.ppat.0040026
Kiu, R., Caim, S., Alexander, S., Pachori, P., and Hall, L. J. (2017). Probing
Genomic Aspects of the Multi-Host Pathogen Clostridium Perfringens Reveals
Significant Pangenome Diversity, and a Diverse Array of Virulence Factors.
Front. Microbiol. 8, 2485. doi: 10.3389/fmicb.2017.02485
Kumar, S., Stecher, G., Li, M., Knyaz, C., and Tamura, K. (2018). MEGA X:
Molecular Evolutionary Genetics Analysis Across Computing Platforms. Mol.
Biol. Evol. 35, 1547–1549. doi: 10.1093/molbev/msy096
Lepp, D., Roxas, B., Parreira, V. R., Marri, P. R., Rosey, E. L., Gong, J., et al. (2010).
Identification of Novel Pathogenicity Loci in Clostridium Perfringens Strains
That Cause Avian Necrotic Enteritis. PloS. One 5 (5), e10795. doi: 10.1371/
journal.pone.0010795
Li, J., Freedman, J. C., Evans, D. R., and McClane, B. A. (2017). Cody Promotes
Sporulation and Enterotoxin Production by Clostridium Perfringens Type a
Strain SM101. Infect. Immun. 85 (3), e00855-16. doi: 10.1128/IAI.00855-16
Li, C., Lillehoj, H. S., Gadde, U. D., Ritter, D., and Oh, S. (2017). Characterization
of Clostridium Perfringens Strains Isolated From Healthy and Necrotic
Enteritis-Afflicted Broiler Chickens. Avian Dis. 61, 178–185. doi: 10.1637/
11507-093016-Reg.1
Li, C. Z., Yan, X., and Lillehoj, H. S. (2020). Comparison Genomics of Two Closely
Related Isolates of Clostridium Perfringens Full Genome Sequences Reveals
Regions of Genome Plasticity With Prevention Potential. J. Immunol. 198,
226.9. doi: 10.1186/s13099-017-0217-6
Long, J. R., Pettit, J. R., and Barnum, D. A. (1974). Necrotic Enteritis in Broiler
Chickens. II. Pathology and Proposed Pathogenesis. Can. J. Comp. Med. Rev.
Can. Med. Comp. 38, 467–474.
Matsushita, O., and Okabe, A. (2001). Clostridial Hydrolytic Enzymes Degrading
Extracellular Components. Toxicon. Off. J. Int. Soc Toxinol. 39, 1769–1780. doi:
10.1016/S0041-0101(01)00163-5
Matsushita, O., Yoshihara, K., Katayama, S., Minami, J., and Okabe, A. (1994).
Purification and Characterization of Clostridium Perfringens 120-Kilodalton
Collagenase and Nucleotide Sequence of the Corresponding Gene. J.Bacteriol.
176, 149–156. doi: 10.1128/JB.176.1.149-156.1994
Medvecky, M., Cejkova, D., Polansky, O., Karasova, D., Kubasova, T., Cizek, A.,
et al. (2018). Whole Genome Sequencing and Function Prediction of 133 Gut
Anaerobes Isolated From Chicken Caecum in Pure Cultures. BMC Genomics
19 (1), 561. doi: 10.1186/s12864-018-4959-4
Mehdizadeh Gohari, I., Kropinski, A. M., Weese, S. J., Parreira, V. R., Whitehead, A. E.,
Boerlin, P., et al. (2016). Plasmid Characterization and Chromosome Analysis of
Two Netf+ Clostridium Perfringens Isolates Associated With Foal and Canine
Necrotizing Enteritis. PloS One 11 (2), e0148344. doi: 10.1371/journal.pone.0148344
Mehdizadeh Gohari, I., Kropinski, A. M.,Weese, S. J., Whitehead, A. E., Parreira, V. R.,
Boerlin, P., et al. (2017). Netf-Producing Clostridium Perfringens: Clonality and
Plasmid Pathogenicity Loci Analysis. Infect. Genet. Evol. J. Mol. Epidemiol. Evol.
Genet. Infect. Dis. 49, 32–38. doi: 10.1016/j.meegid.2016.12.028Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12Möllby, R., Holme, T., Nord, C. E., Smyth, C. J., and Wadström, T. (1976).
Production of Phospholipase C (Alpha-Toxin), Haemolysins and Lethal
Toxins by Clostridium Perfringens Types a to D. J. Gen. Microbiol. 96, 137–
144. doi: 10.1099/00221287-96-1-137
Niilo, L. (1980). Clostridium Perfringens in Animal Disease: A Review of Current
Knowledge. Can. Vet. J. 21, 141–148.
Obana, N., Nomura, N., and Nakamura, K. (2013). Structural Requirement in
Clostridium Perfringens Collagenase Mrna 5′ Leader Sequence for
Translational Induction Through Small RNA-Mrna Base Pairing. J. Bacteriol.
195, 2937–2946. doi: 10.1128/JB.00148-13
Obana, N., Shirahama, Y., Abe, K., andNakamura, K. (2010). Stabilization of Clostridium
Perfringens Collagenase Mrna by VR-RNA-Dependent Cleavage in 5’ Leader
Sequence. Mol. Microbiol. 77, 1416–1428. doi: 10.1111/j.1365-2958.2010.07258.x
Olkowski, A. A., Wojnarowicz, C., Chirino-Trejo, M., and Drew, M. D. (2006).
Responses of Broiler Chickens Orally Challenged With Clostridium
Perfringens Isolated From Field Cases of Necrotic Enteritis. Res. Vet. Sci. 81,
99–108. doi: 10.1016/j.rvsc.2005.10.006
Olkowski, A. A., Wojnarowicz, C., Chirino-Trejo, M., Laarveld, B., and Sawicki, G.
(2008). Sub-Clinical Necrotic Enteritis in Broiler Chickens: Novel Etiological
Consideration Based on Ultra-Structural and Molecular Changes in the
Intestinal Tissue. Res. Vet. Sci. 85, 543–553. doi: 10.1016/j.rvsc.2008.02.007
Parreira, V. R., Russell, K., Athanasiadou, S., and Prescott, J. F. (2016).
Comparative Transcriptome Analysis by Rnaseq of Necrotic Enteritis
Clostridium Perfringens During in Vivo Colonization and in Vitro
Conditions. BMC Microbiol. 16 (1), 186. doi: 10.1186/s12866-016-0792-6
Ren, Z., Guo, C., Yu, S., Zhu, L., Wang, Y., Hu, H., et al. (2019). Int. J. Mol. Sci. 20
(11), 2777. doi: 10.3390/ijms20112777
Ribeiro, F. J., Przybylski, D., Yin, S., Sharpe, T., Gnerre, S., Abouelleil, A., et al.
(2012). Finished Bacterial Genomes From Shotgun Sequence Data. Genome
Res. 22, 2270–2277. doi: 10.1101/gr.141515.112
Roach, D. J., Burton, J. N., Lee, C., Stackhouse, B., Butler-Wu, S. M., Cookson, B.
T., et al. (2015). A Year of Infection in the Intensive Care Unit: Prospective
Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic
Transmissions and Novel Microbiota. PloS Genet. 11 (7), e1005413.
doi: 10.1371/journal.pgen.1005413
Rood, J. I., Adams, V., Lacey, J., Lyras, D., McClane, B. A., Melville, S. B., et al.
(2018). Expansion of the Clostridium Perfringens Toxin-Based Typing
Scheme. Anaerobe. 53, 5–10. doi: 10.1016/j.anaerobe.2018.04.011
Rood, J. I., Keyburn, A. L., and Moore, R. J. (2016). Netb and Necrotic Enteritis:
The Hole Movable Story. Avian Pathol. J. WVPA 45, 295–301. doi: 10.1080/
03079457.2016.1158781
Rozario, T., and DeSimone, D. W. (2010). The Extracellular Matrix in
Development and Morphogenesis: A Dynamic View. Dev. Biol. 341, 126–
140. doi: 10.1016/j.ydbio.2009.10.026
Sand, J. M. B., Genovese, F., Gudmann, N. S., and Karsdal, M. A. (2019). “Chapter
4 - Type IV Collagen,” in Biochemistry of Collagens, Laminins and Elastin, 2nd
ed. Ed. M. A. M.A. Karsdal (Cambridge, Massachusetts, USA: Cambridge,
Academic Press), 37–49.
Scheirlinck, I., Van der Meulen, R., Van Schoor, A., Vancanneyt, M., De Vuyst, L.,
Vandamme, P., et al. (2007). Influence of Geographical Origin and Flour Type
on Diversity of Lactic Acid Bacteria in Traditional Belgian Sourdoughs. Appl.
Environ. Microbiol. 73, 6262–6269. doi: 10.1128/AEM.00894-07
Sheedy, S. A., Ingham, A. B., Rood, J. I., and Moore, R. J. (2004). Highly Conserved
Alpha-Toxin Sequences of Avian Isolates of Clostridium Perfringens. J. Clin.
Microbiol. 42, 1345–1347. doi: 10.1128/JCM.42.3.1345-1347.2003
Shimizu, T., Ohshima, S., Ohtani, K., Shimizu, T., and Hayashi, H. (2001).
Genomic Map of Clostridium Perfringens Strain 13. Microbiol. Immunol. 45,
179–189. doi: 10.1111/j.1348-0421.2001.tb01278.x
Singh, B., Fleury, C., Jalalvand, F., and Riesbeck, K. (2012). Human Pathogens
Utilize Host Extracellular Matrix Proteins Laminin and Collagen for Adhesion
and Invasion of the Host. FEMS. Microbiol. Rev. 36, 1122–1180. doi: 10.1111/
j.1574-6976.2012.00340.x
Tomlin, H., and Piccinini, A. M. (2018). A Complex Interplay Between the
Extracellular Matrix and the Innate Immune Response to Microbial Pathogens.
Immunology. 155, 186–201. doi: 10.1111/imm.12972
Uzal, F. A., Vidal, J. E., McClane, B. A., and Gurjar, A. A. (2010). Clostridium
Perfringens Toxins Involved in Mammalian Veterinary Diseases. Open
Toxinol. J. 2, 24–42. doi: 10.2174/1875414701003020024April 2021 | Volume 11 | Article 645248
Van Damme et al. Protein Truncating Variants in colAVan Damme, L., Cox, N., Callens, C., Haesebrouck, F., Dargatz, M., Ducatelle, R.,
et al. (2020). C. Perfringens Challenge Reduces Matrix Metalloproteinase
Activity in the Jejunal Mucosa of Eimeria-Infected Broiler Chickens. Vet.
Res. 51 (1), 100. doi: 10.1186/s13567-020-00825-6
Wong, Y. M., Juan, J. C., Gan, H. M., and Austin, C. M. (2014). Draft Genome
Sequence of Clostridium Perfringens Strain JJC, a Highly Efficient Hydrogen
Producer Isolated From Landfill Leachate Sludge. Genome Announc. 2 (2),
e00064–14. doi: 10.1128/genomeA.00064-14
Conflict of Interest: Authors MD, MF, SH, FT, and SP were employed by the
company Evonik Operations GmbH.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 13The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Copyright © 2021 Van Damme, Cox, Callens, Dargatz, Flügel, Hark, Thiemann,
Pelzer, Haesebrouck, Ducatelle, Van Immerseel and Goossens. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.April 2021 | Volume 11 | Article 645248
